NEW YORK, August 8, 2017 /PRNewswire/ --
Ortoli Rosenstadt LLP announced today that it represented Q Biomed Inc. ("QBIO"), a biomedical acceleration and development company, in a $3,050,390 equity financing in which Brookline Capital Markets, a division of CIM Securities, LLC, acted as the placement agent. The financing was in the form of 953,247 units with each unit consisting of one share of common stock priced at $3.20 and a five-year warrant to purchase one additional share of common stock at $4.50 for a total of $3,050,390.
William Rosenstadt, of Ortoli Rosenstadt LLP, stated, "As one of the Co-founders of QBIO, I am proud to be able to help it progress its business plan to the next level. It is also important to acknowledge the valuable contributions of Tim Dockery and James Gaskill at Ortoli Rosenstadt in completing the offering."
About Ortoli Rosenstadt LLP
Founded in 2006, Ortoli Rosenstadt LLP is a New York law firm representing domestic and international clients worldwide with vision and ambition. With its attorneys' abilities to speak nine languages, the firm is able to provide cutting-edge and solution-oriented legal advice to international clients globally in a broad variety of practice areas, including corporate & securities, merger and acquisitions, real estate, immigration and employment, intellectual property, commercial litigation and media and entertainment.
Address: 501 Madison Ave, 14th Floor
New York, NY 10022
SOURCE Ortoli Rosenstadt LLP